The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
vTv Therapeutics Inc(NASDAQ:VTVT) 
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops, and sells orally administered small molecule drug candidates to fill unmet medical needs. The company is developing TTP399, an orally administered, small molecule, liver-selective glucokinase activator for the tr...
Website: http://www.vtvtherapeutics.com
Founded: 2015
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology
vTv Therapeutics Days Payable Outstanding ttm (DPO)
vTv Therapeutics Days Receivable Outstanding ttm (DSO)
vTv Therapeutics Op Cashflow Per Share ttm
vTv Therapeutics Free Cashflow Per Share ttm
vTv Therapeutics Cash Per Share ttm
vTv Therapeutics P/S ratio ttm
vTv Therapeutics (GAAP) P/E ratio ttm
vTv Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.